Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting
163 studies found for:    Open Studies | "Thyroid Neoplasms"
Show Display Options
Rank Status Study
21 Recruiting Vemurafenib Neoadjuvant Trial in Locally Advanced Thyroid Cancer
Condition: Thyroid Cancer
Interventions: Drug: Vemurafenib (All Groups);   Drug: Vemurafenib (Post Surgery) - Group A + C;   Other: Post Surgery - Group B
22 Unknown  Recombinant Thyrotropin PET-CT Fusion Scanning in Thyroid Cancer
Condition: Thyroid Cancer
Intervention: Drug: Recombinant thyrotropin
23 Recruiting Phase II Study Assessing the Efficacy and Safety of Lenvatinib for Anaplastic Thyroid Cancer
Condition: Anaplastic Thyroid Cancer
Intervention: Drug: Lenvatinib
24 Recruiting Safety and Efficacy of Sorafenib in Patients With Advanced Thyroid Cancer: a Phase II Clinical Study
Condition: Thyroid Cancer
Intervention: Drug: Sorafenib
25 Recruiting Thyroid Cancer Among Chornobyl Clean-up Workers in Ukraine: Pilot Study
Condition: Thyroid Cancer
Intervention:
26 Recruiting Clinical and Genetic Studies in Familial Non-medullary Thyroid Cancer
Condition: Non-Medullary Thyroid Cancer
Intervention:
27 Unknown  Influence of Thyroid Hormones on the Woundhealing Process
Conditions: Thyroid Neoplasms;   Thyroid Carcinoma
Intervention: Procedure: blood sampling
28 Recruiting Trametinib in Increasing Tumoral Iodine Incorporation in Patients With Recurrent or Metastatic Thyroid Cancer
Conditions: Poorly Differentiated Thyroid Gland Carcinoma;   Recurrent Thyroid Gland Carcinoma;   Stage IVA Thyroid Gland Follicular Carcinoma;   Stage IVA Thyroid Gland Papillary Carcinoma;   Stage IVB Thyroid Gland Follicular Carcinoma;   Stage IVB Thyroid Gland Papillary Carcinoma;   Stage IVC Thyroid Gland Follicular Carcinoma;   Stage IVC Thyroid Gland Papillary Carcinoma
Interventions: Procedure: Computed Tomography;   Radiation: Iodine I 124;   Radiation: Iodine I-131;   Other: Laboratory Biomarker Analysis;   Other: Pharmacological Study;   Procedure: Positron Emission Tomography;   Drug: Trametinib
29 Recruiting Iodine I-131 With or Without Selumetinib in Treating Patients With Recurrent or Metastatic Thyroid Cancer
Conditions: Poorly Differentiated Thyroid Gland Carcinoma;   Recurrent Thyroid Gland Carcinoma;   Stage IVA Thyroid Gland Follicular Carcinoma;   Stage IVA Thyroid Gland Papillary Carcinoma;   Stage IVB Thyroid Gland Follicular Carcinoma;   Stage IVB Thyroid Gland Papillary Carcinoma;   Stage IVC Thyroid Gland Follicular Carcinoma;   Stage IVC Thyroid Gland Papillary Carcinoma
Interventions: Radiation: Iodine I-131;   Other: Laboratory Biomarker Analysis;   Other: Placebo;   Drug: Selumetinib
30 Recruiting A Study of Two Different Doses of Cabozantinib (XL184) in Progressive, Metastatic Medullary Thyroid Cancer
Condition: Medullary Thyroid Cancer
Interventions: Drug: Cabozantinib (XL184) 140 mg;   Drug: Cabozantinib (XL184) 60 mg;   Drug: Placebo tablet;   Drug: Placebo capsule
31 Recruiting Diagnosing Thyroid Cancer Using a Blood Test
Condition: Differentiated Thyroid Cancer
Intervention:
32 Recruiting Determination of Pronostics Factors for Advanced Thyroid Carcinoma (pT3 pT4 or M1 at Diagnosis)
Condition: Thyroid Cancer
Intervention: Other: follow up visit
33 Recruiting A Study Using Regorafenib as Second or Third Line Therapy in Metastatic Medullary Thyroid Cancer
Condition: Thyroid Cancer
Intervention: Drug: Regorafenib
34 Unknown  Feasibility of Endoscopic Thyroidectomy for Thyroid Carcinoma
Condition: Thyroid Carcinoma
Intervention: Procedure: thyroidectomy
35 Unknown  Radioiodine Dosimetry Protocol for Thyroid Cancer Metastases
Conditions: Thyroid Carcinoma;   Metastatic Sites Lung Bone Nodal
Intervention: Other: SPECT scan
36 Recruiting The Use of Candy and Honey in Decreasing Salivary Gland Damage Following Radioiodine Therapy for Thyroid Cancer
Condition: Thyroid Cancer
Intervention: Dietary Supplement: thymus honey mouthwash
37 Unknown  The Effect of Coffee on the Absorption of Thyroid Hormone in Patients With Thyroid Carcinoma
Conditions: Thyroid Carcinoma;   Hypothyroidism
Interventions: Other: Black Coffee;   Other: Coffee with Milk;   Other: Black Tea;   Other: Water
38 Unknown  BRAF V600E Mutations In Papillary Thyroid Carcinoma
Condition: Papillary Thyroid Carcinoma
Intervention: Genetic: BRAF V600E POSITIVITY
39 Recruiting Phase II Study of the Optimal Scheme of Administration of Pazopanib in Thyroid Carcinoma
Condition: Thyroid Carcinoma
Interventions: Drug: Continuous pazopanib (Arm A);   Drug: Intermittent pazopanib (Arm B)
40 Recruiting Prospective, Non-interventional, Post-authorization Safety Study That Includes All Patients Diagnosed as Unresectable Differentiated Thyroid Carcinoma and Treated With Sorafenib
Condition: Thyroid Carcinoma
Intervention: Drug: Sorafenib (Nexavar, BAY43-9006)

First Page    Show previous page of results Previous Page (1-20) Studies Shown (21-40) Next Page (41-60) Show next page of results    Last Page
Indicates status has not been verified in more than two years